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We investigated the effect of four feed additives, namely β-glucan, a drink-
ing water acidifier (DWA), a sanguinarine-containing product (SN) and fulvic ac-
id, on hepatic cytochrome P450 (CYP) mRNA expression and CYP enzyme activ-
ity in chickens. The test substances were given to the chickens in the recommend-
ed dose or in tenfold dose. The administration of 5 mg/kg body weight (bw) β-
glucan and 0.1 ml/kg bw DWA for five days decreased the relative gene expres-
sion of CYP1A4 and CYP2C23a. The dosing of 50 mg/kg bw β-glucan, 5 and 
50 mg/kg bw SN, 1 ml/kg bw DWA and 250 mg/kg bw fulvic acid doubled the 
hepatic CYP1A4 activity. The activity of CYP2C and CYP3A remained un-
changed. Avoidance of CYP1A-mediated feed–drug interactions requires accurate 
dosing of β-glucan, DWA and fulvic acid. According to our results, no treatment 
resulted in excessive or less CYP2C and CYP3A protein formation, which reduc-
es the risk of potential feed additive–drug interactions in chickens. However, the 
administration of feed additive SN containing a plant alkaloid should be avoided 
concomitantly with CYP1A-metabolised medicines.  
Key words: Chicken, cytochrome P450 mRNA and enzyme activity, feed 
additives  
Domesticated chickens, as one of the most important food protein sources, 
should remain healthy and antimicrobial-free during the entire raising period. 
Feed additives may improve the immunity and feed utilisation of chickens. The 
effect of these feed additives on drug-metabolising enzymes is unknown, alt-
hough the flock may need to be treated at any time during the growing period, 
and it is questionable whether the additives cause any alteration in cytochrome 
P450 (CYP) enzyme activity, which may modify the therapeutic effect of medi-
cines.  
Xenobiotic-metabolising CYPs are known to be expressed primarily in the 
liver, and the most important CYP isoenzymes belong to the families CYP1-3. 
The mRNA expression levels of CYPs are in correlation with their enzymatic ac-
tivity, but the degree of correlation depends on the CYP isoform (Temesvári et 
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al., 2012). Watanabe et al. (2013) found that CYP2C45 showed the highest basal 
mRNA expression in chicken liver, and CYP2C23b gene was the most induced 
gene by phenobarbital followed by CYP2C23a and CYP2C45, although 
CYP2C23a showed higher enzyme activity compared to CYP2C45 after pheno-
barbital exposure. The high abundance of CYP2C subfamily in chickens indi-
cates the importance of these enzymes in avian drug metabolism. Several sub-
stances are available for use as feed additives or drinking water supplementation 
in livestock farming. In our study we investigated the effect of β-glucan, a san-
guinarine-containing product (Sangrovit®), a drinking water acidifier (Immuno-
fort®), and fulvic acid.  
The (1-3), (1-6) β-glucans, the cell wall constituents of fungi, are recog-
nised by mammalian cells as pathogen-associated molecular patterns and thus act 
as biological response modifiers. The fungal β-glucans act as broad-spectrum 
enhancers of host defence mechanisms, positively influencing the immunological 
response of mammals to bacterial, viral, and fungal infections (Palócz and Csikó, 
2014). Sangrovit® is a natural plant-derived (Macleaya cordata) phytogenic feed 
additive containing many benzophenanthridine alkaloid compounds, the most 
abundant of which is sanguinarine (Kantas et al., 2015). Dietary supplementation 
with Sangrovit® significantly improved body weight and feed conversion ratio in 
broiler chickens (Vieira et al., 2008). Immunofort® is a solution for use in drink-
ing water; it contains volatile fatty acids, amino acids, phosphoric acid, zinc and 
copper salt complexes. The aqueous solution of the product contains undissociat-
ed organic acids, which inhibit the growth of pathogenic microorganisms. Fulvic 
acid is one of the most active fractions of humic substances which are commonly 
found in soil. Fulvic acid contains many reactive functional groups, including 
carboxyls, hydroxyls, carbonyls, phenols, quinones, and semiquinones, which are 
responsible for its metal-chelating and antioxidant activity (Plaza et al., 2005). 
Previous studies indicated that fulvic acid formed a film on the mucosal epitheli-
um of the gastrointestinal tract, protected against infections and toxins, and im-
proved the utilisation of nutrients in animal feed (Islam et al., 2005). The chelat-
ing ability of humic substances might enhance the intestinal uptake of microele-
ments (Szabó et al., 2017). Dietary supplementation with fulvic acid improved 
feed efficiency and immunity as well (Chang et al., 2014). 
There is a lack of knowledge about how the applied additives act on the 
pathways of xenobiotic metabolism. If drug therapy becomes necessary in a chick-
en flock, it is important to know how the administered substances alter the cyto-
chrome P450 expression, leading to interactions with the drugs or their metabolites. 
The aim of this study was to investigate the effect of four feed additives, 
namely β-glucan, Immunofort® (a drinking water acidifier, DWA), Sangrovit® (a 
sanguinarine-containing product, SN) and fulvic acid on hepatic CYP mRNA 
expression level and CYP enzyme activity in chickens (Gallus gallus domesticus).  
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Materials and methods 
Housing and treatments of chickens 
Forty-five clinically healthy 31-day-old broiler chickens (Ross 308, Her-
bro Ltd., Hernád, Hungary) were used in this study. The birds were housed in 
stainless steel cages, five birds per cage, acclimated at 20 ± 2 °C on a 12-h light/ 
12-h dark schedule. Non-medicated finisher feed (Purina®) and water were pro-
vided ad libitum. The chickens (mean weight 749 ± 24 g) were randomly divided 
into 9 groups (5 chickens/group) comprising one control group and 8 experi-
mental groups. Four of the 8 experimental groups received the feed additive at the 
recommended dose, while the other four were given a tenfold dose of the additive. 
The groups were as follows: groups receiving β-glucan (5 and 50 mg/kg bw), 
groups receiving the sanguinarine-containing product (SN) (5 and 50 mg/kg bw), 
groups receiving the drinking water acidifier (DWA) (0.1 and 1 ml/kg bw), and 
groups receiving fulvic acid (25 and 250 mg/kg bw). The test substances were 
freshly dissolved in water daily and were administered via crop tube (2 ml/kg bw) 
to the birds individually for five consecutive days. The controls received the same 
amount of water via crop tube (placebo). One day after the last treatment day the 
chickens were euthanised (Euthasol® 1 ml/kg bw intracoelomally) and their liv-
ers were perfused in situ with physiological saline solution until the blood was 
drained. Then the livers were collected, shock-frozen in liquid nitrogen and 
stored at –80 °C until further processing. 
Feed additives applied 
Baker’s yeast β-glucan (Wellmune WGP®, Biothera Company, USA; main 
component: water-soluble β-(1-3), (1-6)-D-glucan; recommended dose: 5–10 mg/ 
kg body weight). 
Sanguinarine-containing product (Sangrovit® WS, Phytobiotics GmbH, 
Germany; main components: quaternary benzophenanthridine alkaloids and pro-
topine alkaloids; recommended dose: 10–100 g/1000 l drinking water). 
Drinking water acidifier (Immunofort®, Europharmavet Ltd., Hungary; 
main components: formic acid, propionic acid, phosphoric acid, methionine hy-
droxy analogue, zinc, copper; recommended dose: 1 l/1000 l drinking water). 
Fulvic acid (Fulvix pulvis®, Alpha-Vet Ltd./Organit Ltd., Hungary; main 
component: fulvic acid: 70%; recommended dose: 250 g/1000 l drinking water) 
(Palócz et al., 2019). 
Microsome separation 
The livers were homogenised with two volumes of ice-cold buffer (1.15% 
KCl, 0.1 mM EDTA, pH 7.4) by a Potter-Elvehjem homogeniser (Schuett Biotec 
GmbH, Göttingen, Germany). Microsomes were isolated by two-step differential 
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ultracentrifugation (Beckman L7-65 Ultracentrifuge, Beckman-Coulter) accord-
ing to Nebbia et al. (2001). Protein concentrations were measured by Pierce™ 
BCA protein assay kit (ThermoFisher Scientific, Waltham, MA, USA). 
Quantitative real-time PCR 
The liver samples (100 mg) were homogenised in 1 ml of ice-cold RNAzol 
RT reagent (Sigma-Aldrich, Steinheim, Germany) by a Potter-Elvehjem homog-
eniser (Schuett Biotec GmbH, Göttingen, Germany). Total RNA was isolated from 
the tissue samples according to the manufacturer’s instructions. Quantity, A260/ 
A280 and A260/A230 ratios of the extracted RNA were determined using a 
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, USA). 
Quantitative real-time PCR (qPCR) was performed as described previously (Palócz 
et al., 2017). The tested genes of interest were the avian cytochrome P450 1A4 
(CYP1A4, formerly known as CYP1A1), cytochrome P450 2C23a (CYP2C23a, 
formerly known as CYP2H1), cytochrome P450 2C45 (CYP2C45) and cytochrome 
P450 3A37 (CYP3A37). As reference (housekeeping) genes glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and β-actin were selected. The primer se-
quences are listed in Table 1. The thermal profile for all reactions was 2 min at 
95 °C, then 30 cycles of 10 sec at 95 °C, 20 sec at 56 °C, and 10 sec at 72 °C. 
Cytochrome P450 activity 
The CYP1A4, CYP3A and CYP2C activities of liver microsome samples 
were measured using the P450-Glo™ substrates (Luciferin-CEE, Luciferin-IPA, 
Luciferin-ME; Promega, Madison, USA) (Palócz et al., 2017). The assays were 
performed according to the manufacturer’s recommendation; the luminogenic 
substrates and the NADPH regeneration system (Promega, Madison, USA) were 
added to each 5-fold diluted microsome sample, respectively. After the required 
time the Luciferin Detection Reagents (Promega, Madison, USA) were added to 
the mixture and the formed luminescence signal was detected by a luminometer 
(Victor X2, PerkinElmer, Massachusetts, USA). 
Statistical analyses 
Relative gene expression levels of the genes of interest were calculated by 
the Relative Expression Software Tool (REST) 2009 Software. Statistical anal-
yses were performed by Statistica 13 software (Dell Inc., Round Rock, USA). 
Differences between means were evaluated by one-way analysis of variance 
(ANOVA) followed by a post hoc comparison using Dunnett’s test. 
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Ethical approval 
The animal trials were conducted according to approved laboratory animal 
experimentation ethics in conformity with the national and European law, in a 
manner compatible with the conditions set up by the Guidelines for Ethical Con-
duct in the Care and Use of Nonhuman Animals in Research. The study was au-
thorised by the Local Institutional Animal Care Committee of the Faculty of 
Veterinary Science, Szent István University (no. 27/2015). 
 
 
Results 
The microsome protein concentration was practically equal (23.17 ± 
1.52 mg/ml) in each sample. The activities of CYP1A4, CYP2C and CYP3A are 
shown in Figs 1, 2 and 3, respectively. The administration of 50 mg/kg bw β-
glucan, 5 mg/kg bw SN, 50 mg/kg bw SN, 250 mg/kg bw fulvic acid and 1 ml/kg 
bw DWA to the chickens significantly increased the hepatic CYP1A4 activity 
(P = 0.002, P = 0.010, P = 0.015, P < 0.001 and P < 0.001, respectively; Fig. 1). 
The water-soluble feed additives applied orally for five consecutive days did not 
alter the activity of chicken hepatic CYP2C and CYP3A enzymes (Figs 2 and 3). 
 
Fig. 1. Changes in cytochrome P450 1A4 enzyme activity in chicken liver microsomes (n = 5/group;  
*P < 0.05; **P < 0.01, ***P < 0.001; each treatment group compared to control). Data are shown as 
mean ± SD. SN – Sanguinarine-containing product, DWA – drinking water acidifier.  
The chickens were treated orally for 5 days 
 
The results of chicken CYP450 gene expression levels normalised to two 
housekeeping genes are shown in Fig. 4. Treatment with 5 mg/kg bw β-glucan 
and 0.1 ml/kg bw DWA downregulated the relative gene expression of CYP1A4 
and CYP2C23a. The level of CYP1A4 mRNA decreased to 36%, 60% and 53% 
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after 50 mg/kg bw β-glucan, 5 mg/kg bw SN and 1 ml/kg bw DWA administra-
tion, respectively. Furthermore, the administration of 50 mg/kg bw SN resulted 
in a 64% downregulation of the CYP2C23a gene. 
 
Fig. 2. Changes in cytochrome P450 2C enzyme activity in chicken liver microsomes (n = 5/group; 
the level of significance was set at P < 0.05; each treatment group compared to control). Data are 
shown as mean ± SD. SN – Sanguinarine-containing product, DWA – drinking water acidifier.  
The chickens were treated orally for 5 days 
 
Fig. 3. Changes in cytochrome P450 3A enzyme activity in chicken liver microsomes (n = 5/group; 
the level of significance was set at P < 0.05; each treatment group compared to control). Data are 
shown as mean ± SD. SN – Sanguinarine-containing product, DWA – drinking water acidifier.  
The chickens were treated orally for 5 days 
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Discussion 
In general, the administration of feed additives to chicken flocks is proven 
to be effective for promoting their health or weight gain during the growing peri-
od. Although they are suspected to be safe, it is presumed that orally absorbed 
feed additives may influence the metabolism of drugs through the enzymes of 
phase I and/or phase II reaction; however, few studies have defined the actual ex-
tent of these effects (Fink-Gremmels, 2008; Csikó et al., 2014; de Boer et al., 
2015). The altered metabolic pattern of medicines may influence their therapeu-
tic activity in the treated flocks and their residue levels in foods. 
In this study the activity of CYP1A enzyme was enhanced after the admin-
istration of both the recommended and the tenfold dose of SN which can be ex-
plained by the fact that polycyclic aromatic substances are metabolised via this 
enzyme family (Sridhar et al., 2017), hence SN, a product containing quaternary 
benzophenanthridine alkaloids and protopine, provoked the activity of CYP1A 
enzymes. The other three tested feed additives increased the activity of CYP1A 
enzymes in the tenfold dose but not in the recommended dose, a finding that 
draws attention to the importance of dosing these substances in a precise manner. 
There are several differences in catalytic profiles of the chicken CYP3A37 
and the human and canine CYP3A enzymes. Interestingly, CYP2C23a behaves, 
in regard to regulation, very similarly to CYP3A37 (Ourlin et al., 2000). The 
chicken CYP3A37 has relatively low abundance, which suggests that this is not 
the most important isoenzyme in the metabolism of xenobiotics (Watanabe et al., 
2013). CYP2C enzymes play major roles in the detoxification of xenobiotics 
(Carre et al., 2002) and their high abundance in the liver makes them the primary 
drug-metabolising factors. In our study, the gene expression of CYP2C23a was 
decreased on some occasions; however, the activity of CYP2C enzymes did not 
change following the administration of the four feed additives examined. Inter-
estingly, the gene expression level of CYP1A4 was decreased after the admin-
istration of β-glucan, SN and DWA; in contrast, the same treatments increased 
the activity of CYP1A4. This contradiction can be the consequence of the sam-
pling time; both the mRNA samples and the microsome samples were collected 
at the same time, so it is possible that the gene expression phase has been down-
regulated due to a feedback resulting from excess protein formation. Downregu-
lation of the CYP2C23a gene may also be a consequence of a negative feedback 
as the formed CYP2C23a mRNA may inhibit the transcription of its own gene, 
since the activity of CYP2C remained unaltered after the treatments. Nonetheless, 
to prove this assumption further experiments would be necessary with more fre-
quent sampling periods to monitor the continuity of changes in gene expression. 
In conclusion, supplementation of the chickens’ drinking water with β-
glucan, SN, DWA or fulvic acid may cause cytochrome P450-mediated interac-
tions, particularly with substances which are metabolised via the CYP1A en-
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zymes. This subfamily metabolises a smaller proportion of medicines and none 
of them are antimicrobials. Benzimidazole anthelmintic drugs have the highest 
possibility of interaction with feed additives on CYP1A enzymes (Diani-Moore 
et al., 2006) in the chicken industry, especially when certain feed additives are 
overdosed or supplements containing plant alkaloids are used. Care should be 
taken during antiparasitic therapy of the flock if the applied feed additive con-
tains polycyclic aromatic amines such as quaternary benzophenanthridine alka-
loids and protopine alkaloids. 
The activity of the avian CYP2C, which is considered the most significant 
in avian drug metabolism, remained unchanged after the administration of each 
feed additive in either dose; consequently, clinically important alterations in the 
CYP-mediated antimicrobial metabolism have low probability. Especially the 
application of fulvic acid seems to be the safest with regard to possible feed–drug 
interactions, since neither the activity nor the gene expression of CYP2Cs was al-
tered after five-day administration of the substance. Further investigations are 
needed to clarify the changes in the gene expression profile of CYP genes. Based 
on our results none of the treatments resulted in excess CYP2C or CYP3A pro-
tein, which reduces the emerging risk of interactions between the tested feed ad-
ditives and drugs. 
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